Cryosite (ASX:CTE) NonCurrent Deferred Liabilities : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Cryosite NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Cryosite's non-current deferred liabilities for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Cryosite NonCurrent Deferred Liabilities Historical Data

The historical data trend for Cryosite's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryosite NonCurrent Deferred Liabilities Chart

Cryosite Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

NonCurrent Deferred Liabilities

Get a 7-Day Free Trial

20.28

18.15

16.13

14.17

12.54

Cryosite Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
NonCurrent Deferred Liabilities	Get a 7-Day Free Trial															-	14.17	-	12.54	-

Cryosite NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Cryosite's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryosite (ASX:CTE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cryosite Ltd (ASX:CTE) » Definitions » NonCurrent Deferred Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

13a Ferndell Street, South Granville, Sydney, NSW, AUS, 2142

Website

https://www.cryosite.com

Cryosite Ltd is engaged in the provision of supply chain logistics, management of pharmaceutical products used in clinical trials. The company's operating segment includes Cord Blood and Tissue Storage and Clinical Trials and Biological Services Logistics. It generates maximum revenue from the Clinical Trials and Biological Services Logistics segment. Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services.

Cryosite (ASX:CTE) Headlines

No Headlines